Papers

4

Total Citations

54

H-Index

4

About

Ningyuan Zou is a leading thoracic surgeon whose research focuses on optimizing minimally invasive surgical approaches for non-small cell lung cancer (NSCLC), particularly through comparative studies of robot-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS). Dr. Zou’s major contributions include demonstrating the feasibility and oncologic efficacy of RATS in challenging clinical scenarios, such as after neoadjuvant immunochemotherapy, in octogenarians with early-stage disease, and in young adults aged 35 or younger. Notably, their work on lymph node dissection quality and early recurrence in stage N1-2 NSCLC, based on eleven years of real-world data from a high-volume center, provides critical insights into surgical precision and long-term outcomes. With several papers accumulating 14–17 citations each, Dr. Zou’s research is shaping best practices in thoracic oncology, offering evidence that RATS may offer advantages over VATS in specific patient populations. Their studies, grounded in propensity score-matched analyses, are essential reading for surgeons and researchers seeking to refine surgical strategies and improve survival in NSCLC patients.

Research Focus

Key Achievements

4
H-Index
4
Papers
54
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study
17 citations · 2023
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago